Layoffs at Elevation Oncology
- Layoff events
- 2
- verified and sourced
- Roles reported
- Not stated
- no source gives a number
- Announced between
- Jan 2023 to Mar 2025
- Reported by
- Elevation Oncology / U.S. SEC and Fierce Biotech
This page records what we could verify and source. It is not a complete record of every job cut at Elevation Oncology: a layoff nobody published and nobody sent us is a layoff that is not on this page.
| Company | What happened | Roles reported | Share of staff | Where | Announced | Sources |
|---|---|---|---|---|---|---|
| Elevation Oncology |
Pipeline setback
Elevation Oncology discontinued EO-3021 after updated clinical data and announced an approximately 70% workforce reduction while evaluating strategic options. |
Not known | 70% | Company-wide |
1 source for Elevation Oncology |
|
| Elevation Oncology |
Pipeline setback
Elevation Oncology announced a 30% workforce reduction while pausing development of seribantumab and reshaping its pipeline. |
Not known | 30% | United States |
1 source for Elevation Oncology |
Where this comes from
Every cut listed for Elevation Oncology was entered by a person who checked it against a filing or a named report. Nothing is scraped and nothing publishes itself. What is not here is what we have not verified, not what did not happen.
Spotted something wrong or missing about Elevation Oncology? Tell us on our Discord and we will check it.